FAS and fatty liver disease: Recently, in addition to its role in apoptosis, Fas has been shown to promote hepatic steatosis and IR by compromising mitochondrial fatty acid oxidation via the hepatic activation of BH3 interacting-domain death agonist in mice with liver-specific Fas overexpression [41].